ArticleOncology and therapy2016

Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma.

Jordan Amdahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.